Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

Authors :: Autore F
Visentin A
Deodato M
Vitale C
Galli E
Fresa A
Fazzi R
Sanna A
Olivieri J
Scortechini I
Del Principe MI
Sportoletti P
Schiattone L
Maschio N
Facchinelli D
Marchesi F
Coscia M
Tedeschi A
Trentin L
Innocenti I
Candoni A
Busca A
Pagano L
Laurenti L
Source :: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 982-984. Date of Electronic Publication: 2024 Feb 11.
Publication Year :: 2024

Subjects :: Humans
Bridged Bicyclo Compounds, Heterocyclic adverse effects
Risk Factors
Antineoplastic Combined Chemotherapy Protocols adverse effects
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Antineoplastic Agents therapeutic use
Sulfonamides

Full Text Access

Tools